Li-An Medical Clinic, Taipei City, Taiwan.
Kaohsiung Jourdenwell Aesthetic Clinic, Kaohsiung, Taiwan.
J Cosmet Dermatol. 2022 Oct;21(10):4328-4331. doi: 10.1111/jocd.15047. Epub 2022 May 16.
Filler injection for lower eyelid rejuvenation remains a difficult subject due to many complicated anatomic changes as the face ages.
To propose an alternative, simple, and effective filler injection method in lower eyelids for Asian patients.
Any patient who has tear trough deformities, infra-orbital hollows, nasojugal grooves, dark eye circles, as well as mild eyebags is a potential candidate for this method. Our filler choice is injectable poly-d,l-lactic acid (PDLLA; AestheFill; REGEN). PDLLA must be reconstituted with sterile water for injection (SWFI) before administration. When the patient's troughs, grooves, or volume deficit are classes II and III, 3-4 ml of SWFI and 1 ml of lidocaine are used. When the deficits are class I, 5-7 ml of SWFI and 1 ml of lidocaine are used. With the fanning injection technique, a wide region that covers all the deficits is evenly injected. The depth is under the dermis layer. The total amount of filler injection is not more than 2 ml on each side.
Since 2019, we have injected more than 100 patients by following these steps in Taiwan. The level of patient satisfaction is high. Only some mild and transient post-injection complications such as edema, erythema, and ecchymosis were found.
We propose an alternative, simple and effective method for non-surgical lower eyelid rejuvenation for Asian patients. However, anyone who wants to perform this procedure should be well-trained and knowledgeable about the anatomy, product, and procedure to prevent adverse events.
由于面部衰老时会发生许多复杂的解剖变化,因此,下眼睑填充剂注射仍然是一个难题。
为亚洲患者提出一种替代的、简单且有效的下眼睑填充剂注射方法。
任何有泪槽畸形、眶下凹陷、鼻颊沟、黑眼圈以及轻度眼袋的患者都是这种方法的潜在候选人。我们的填充剂选择是可注射的聚-DL-乳酸(PDLLA;AestheFill;REGEN)。在给药之前,PDLLA 必须用无菌注射用水(SWFI)重新配制。当患者的泪槽、凹槽或容量不足为 II 类和 III 类时,使用 3-4ml 的 SWFI 和 1ml 的利多卡因。当缺陷为 I 类时,使用 5-7ml 的 SWFI 和 1ml 的利多卡因。采用扇形注射技术,均匀地注射覆盖所有缺陷的宽区域。深度位于真皮层以下。每侧填充剂的总注射量不超过 2ml。
自 2019 年以来,我们在台湾按照这些步骤为 100 多名患者进行了注射。患者满意度很高。仅发现一些轻微和短暂的注射后并发症,如水肿、红斑和瘀斑。
我们为亚洲患者提出了一种替代的、简单且有效的非手术下眼睑年轻化方法。然而,任何想要进行此操作的人都应该接受过关于解剖、产品和程序的良好培训和了解,以预防不良事件。